RECURRENT MENINGIOMA
Clinical trials for RECURRENT MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MENINGIOMA trials appear
Sign up with your email to follow new studies for RECURRENT MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for aggressive brain tumor
Disease control OngoingThis study tests two immunotherapy drugs (nivolumab and ipilimumab) combined with precise radiation for people with a recurrent, high-grade meningioma (a type of brain tumor). The goal is to find the safest dose and see if the treatment can shrink tumors or slow their growth. Abo…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
New radioactive drug shows promise for Hard-to-Treat brain tumors
Disease control TerminatedThis study tests a new drug called RYZ101 for people with meningioma that has come back or is getting worse. The drug delivers radiation directly to tumor cells by targeting a protein found on them. The goal is to see if it is safe and can stop the tumor from growing. About 30 ad…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Joshua Palmer • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New radiation approach targets tough brain tumors
Disease control TerminatedThis early-phase study tests whether giving higher doses of radiation, guided by special PET/MRI scans, is safe for people with high-risk meningiomas (aggressive or recurrent brain tumors). About 24 adults will receive one of four radiation dose levels. The main goal is to find t…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
New combo therapy aims to stop returning brain tumors
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to precise radiation (stereotactic radiosurgery) can help control recurrent meningioma, a type of brain tumor that has come back after prior treatment. About 35 adults with grade II or III meningioma will receiv…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE2 • Sponsor: Nancy Ann Oberheim Bush, MD • Aim: Disease control
Last updated May 06, 2026 16:03 UTC